Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

19.14
+0.30731.63%
Volume:126.95K
Turnover:2.41M
Market Cap:4.55B
PE:22.36
High:19.24
Open:18.85
Low:18.85
Close:18.83
52wk High:25.67
52wk Low:13.50
Shares:238.00M
Float Shares:233.86M
Volume Ratio:0.68
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8560
EPS(LYR):0.8481
ROE:63.17%
ROA:21.76%
PB:10.56
PE(LYR):22.57

Loading ...

ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares

Reuters
·
Yesterday

ADMA Biologics (ADMA): Assessing Valuation as Short Interest Declines and Market Sentiment Improves

Simply Wall St.
·
Nov 27

High Growth Tech Stocks In The US For November 2025

Simply Wall St.
·
Nov 24

ADMA Biologics CEO Adam S. Grossman Reports Disposal of Common Shares

Reuters
·
Nov 22

ADMA Biologics (ADMA) Receives a New Rating from Cantor Fitzgerald

TIPRANKS
·
Nov 06

ADMA Biologics Reports Strong Q3 2025 Financial Results

TIPRANKS
·
Nov 06

Stock Track | ADMA Biologics Plunges 5.72% After-Hours Despite Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 06

BRIEF-ADMA Biologics Q3 Revenue USD 134.2 Million

Reuters
·
Nov 06

ADMA Biologics Inc Outlook 2026 Total Revenue: Raised to at Least $630 Million

THOMSON REUTERS
·
Nov 06

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 06

Adma Biologics options imply 14.3% move in share price post-earnings

TIPRANKS
·
Nov 06

Stock Track | ADMA Biologics Soars 5% Ahead of Expected Strong Q3 Earnings Report

Stock Track
·
Nov 06

Stock Track | ADMA Biologics Soars 5.06% Ahead of Expected Positive Q3 Earnings

Stock Track
·
Nov 06

ADMA Biologics Inc expected to post earnings of 15 cents a share - Earnings Preview

Reuters
·
Nov 04

ADMA Biologics Inc. to Report Third Quarter 2025 Financial Results

Reuters
·
Oct 29

ADMA Biologics CEO Adam S. Grossman Reports Sale of Common Shares

Reuters
·
Oct 25

Assessing ADMA Biologics’s Valuation Following Bold Multi-Year Growth Targets and Manufacturing Upgrades

Simply Wall St.
·
Oct 16

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.
·
Sep 26

ADMA Biologics Inc. President and CEO Adam S. Grossman Reports Disposal of Common Shares

Reuters
·
Aug 16

Stock Track | ADMA Biologics Plummets 17.72% as Q2 Sales Miss Sparks Investor Concerns

Stock Track
·
Aug 07